US Patent Issued to Kite Pharma on Nov. 25 for "Methods and compositions for T cell therapy" (California, Indiana Inventors)

ALEXANDRIA, Va., Nov. 25 -- United States Patent no. 12,480,951, issued on Nov. 25, was assigned to Kite Pharma Inc. (Santa Monica, Calif.).

"Methods and compositions for T cell therapy" was invented by Adrian I. Bot (Beverly Hills, Calif.), Justin Budka (Fishers, Ind.), Szu-Ting Chou (Los Angeles), Francesca Milletti (Manhattan Beach, Calif.), Vicki Plaks (Santa Monica, Calif.) and John M. Rossi (Newbury Park, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure relates to methods of diagnosis and prognosis, compositions for immunotherapies, methods of improving said compositions, and immunotherapies using the same."

The patent was filed on Jan. 7, 2022, under Application No. 17/570,917.

*...